LUMO - LUMOS PHARMA, INC.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 3.0001

Open

$ 3.02

Bid

$ 2.79 x 100

Ask

$ 0.00 x 0

Day's Range

$ 3.02 - $ 3.02

52 Week Range

$ 2.41 - $ 4.55

Volume

12,332

Average Volume

Market Cap

24.44M

Beta (5Y Monthly)

$ -3.21

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-07-2024	12-31-2023	10-K
2	11-07-2023	09-30-2023	10-Q
3	08-10-2023	06-30-2023	10-Q
4	05-05-2023	03-31-2023	10-Q
5	03-07-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-10-2022	06-30-2022	10-Q
8	05-11-2022	03-31-2022	10-Q
9	03-11-2022	12-31-2021	10-K
10	11-05-2021	09-30-2021	10-Q
11	08-06-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	03-09-2021	12-31-2020	10-K
14	11-12-2020	09-30-2020	10-Q
15	08-14-2020	06-30-2020	10-Q
16	06-02-2020	03-31-2020	10-Q
17	03-03-2020	12-31-2019	10-K
18	11-06-2019	09-30-2019	10-Q
19	08-08-2019	06-30-2019	10-Q
20	05-08-2019	03-31-2019	10-Q
21	03-05-2019	12-31-2018	10-K
22	11-02-2018	09-30-2018	10-Q
23	08-06-2018	06-30-2018	10-Q
24	05-09-2018	03-31-2018	10-Q
25	03-05-2018	12-31-2017	10-K
26	11-03-2017	09-30-2017	10-Q
27	08-03-2017	06-30-2017	10-Q
28	05-05-2017	03-31-2017	10-Q
29	03-06-2017	12-31-2016	10-K
30	11-08-2016	09-30-2016	10-Q
31	08-05-2016	06-30-2016	10-Q
32	04-29-2016	03-31-2016	10-Q
33	02-29-2016	12-31-2015	10-K
34	11-06-2015	09-30-2015	10-Q
35	08-06-2015	06-30-2015	10-Q
36	05-11-2015	03-31-2015	10-Q
37	03-16-2015	12-31-2014	10-K
38	11-10-2014	09-30-2014	10-Q
39	08-05-2014	06-30-2014	10-Q
40	05-08-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Lumos Pharma Announces Abstracts Reviewing...
04/18/2024 20:08:11

HC Wainwright & Co. Reiterates Buy on Lumo...
03/20/2024 16:29:58

HC Wainwright & Co. analyst Edward White reiterates Lumos Pharma (NASDAQ:LUMO) with a Buy and maintains $28 price target.

Lumos Pharma Announces USPTO Has Granted P...
03/20/2024 12:06:30

Oppenheimer Maintains Outperform on Lumos ...
03/08/2024 14:04:36

Oppenheimer analyst Leland Gershell maintains Lumos Pharma (NASDAQ:LUMO) with a Outperform and maintains $16 price target.

HC Wainwright & Co. Reiterates Buy on Lumo...
03/08/2024 11:52:01

HC Wainwright & Co. analyst Edward White reiterates Lumos Pharma (NASDAQ:LUMO) with a Buy and maintains $28 price target.

Lumos Pharma: Q4 Earnings Insights
03/07/2024 21:10:07

Lumos Pharma Q4 2023 GAAP EPS $(1.170) Mis...
03/07/2024 21:09:35

Lumos Pharma (NASDAQ:LUMO) reported quarterly losses of $(1.170) per share which missed the analyst consensus estimate of $(1.1...

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

Earnings Preview: Lumos Pharma
03/06/2024 18:01:39

Oppenheimer Maintains Outperform on Lumos ...
12/11/2023 15:21:08

Oppenheimer analyst Leland Gershell maintains Lumos Pharma (NASDAQ:LUMO) with a Outperform and lowers the price target from ...

HC Wainwright & Co. Reiterates Buy on Lumo...
12/07/2023 11:43:35

HC Wainwright & Co. analyst Edward White reiterates Lumos Pharma (NASDAQ:LUMO) with a Buy and maintains $28 price target.

Lumos Pharma To Host Virtual Key Opinion L...
11/21/2023 21:29:37

Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for moderate Pediatric Gr...

why-toast-shares-are-trading-lower-by-around-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Toast Shares Are Trading Lower By Arou...
11/08/2023 18:41:58

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday.

why-is-biomarin--bridgebio-pharma-rival-lumos-pharma-stock-trading-higher-today

Why Is Biomarin & BridgeBio Pharma Rival L...
11/08/2023 18:20:41

Lumos Pharma Inc (NASDAQ: LUMO) announced that topline results from its Phase 2 OraGrowtH210 dose-finding trial and its Phase 2...

Roblox, Under Armour, GoPro, Nuvei And Oth...
11/08/2023 16:02:42

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks reco...

Market-Moving News for November 8th
11/08/2023 13:42:56

LUMO: 154% | Lumos Pharma Announces Topline Data From Phase 2 OraGrowtH210 And OraGrowtH212 Trials Of LUM-201 In PGHD Met All P...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
11/08/2023 13:06:41

why-american-public-education-shares-are-trading-higher-by-around-21-here-are-20-stocks-moving-premarket

Why American Public Education Shares Are T...
11/08/2023 12:49:59

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7%...

Lumos Pharma Q3 EPS $(1.04) Beats $(1.15) ...
11/07/2023 22:05:48

Lumos Pharma (NASDAQ:LUMO) reported quarterly losses of $(1.04) per share which beat the analyst consensus estimate of $(1.15) ...

Lumos Pharma Announces Topline Data From P...
11/07/2023 22:05:19

OraGrowtH210 Results Show LUM-201 Dose of 1.6 mg/kg Achieves Annualized Height Velocities (AHV) of 8.2 cm/yr at 6 Months and 8....